Inventiva SA (NAS:IVA)
$ 1.865 0.025 (1.36%) Market Cap: 97.65 Mil Enterprise Value: 109.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Inventiva SA at Jefferies London Healthcare Conference Transcript

Nov 16, 2022 / NTS GMT
Release Date Price: $4.3 (-1.60%)
Brian Balchin
(Trades, Portfolio) LLC - Analyst

Good morning. Welcome to the Jefferies Healthcare Conference. I'm Brian Balchin, European pharma and biotech analyst at Jefferies. And it's my pleasure to be hosting Frédéric Cren, CEO of Inventiva. So I think we'll just kick off with a small presentation before then going to Q&A.

FrÃ;dÃ;ric Cren
Inventiva - CEO & Co-Founder

©© -

Great. Thank you. I'm Frédéric, I'm the CEO and Co-Founder of Inventiva. Very nice to see you all here. So before the fireside, I just thought we are going to present a couple of slides. Of course, the disclaimer and the forward-looking statements.

So about Inventiva. So what is important? We have a Phase III asset in NASH with extremely

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot